TG Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	8,095	4,630	4,691	2,586	1,732	2,722
Market Cap Growth	36.85%	-1.30%	81.36%	49.35%	-36.37%	-62.78%
Enterprise Value	8,334	4,741	4,633	2,480	1,653	2,486
Last Close Price	57.12	29.81	30.10	17.08	11.83	19.00
PE Ratio	19.90	10.76	200.67	189.78	-	-
Forward PE	32.64	20.29	45.21	-	-	-
PS Ratio	11.56	7.51	14.26	11.07	621.81	406.90
PB Ratio	13.88	7.14	21.09	16.11	29.56	11.48
P/TBV Ratio	15.75	7.43	21.70	15.80	27.72	10.63
EV/Sales Ratio	11.90	7.69	14.08	10.61	593.58	371.66
EV/EBITDA Ratio	55.72	38.43	110.33	118.96	-	-
EV/EBIT Ratio	55.75	38.45	110.51	120.18	-	-
Debt / Equity Ratio	1.29	0.39	1.14	0.68	1.39	0.32
Debt / EBITDA Ratio	5.04	2.06	6.04	5.32	-	-
Net Debt / Equity Ratio	0.41	0.17	-0.26	-0.66	-1.34	-0.99
Net Debt / EBITDA Ratio	1.60	0.91	-1.36	-5.12	0.36	0.68
Net Debt / FCF Ratio	-16.85	-4.47	1.41	3.40	0.45	0.80
Asset Turnover	0.54	0.75	0.73	0.89	0.01	0.01
Inventory Turnover	0.93	0.85	0.51	0.71	-	-
Quick Ratio	4.84	2.91	4.85	5.00	3.04	4.84
Current Ratio	5.81	4.10	6.25	5.92	3.16	5.06
Return on Equity (ROE)	75.03%	102.75%	12.21%	11.57%	-151.36%	-92.03%
Return on Assets (ROA)	-22.64%	-32.53%	10.04%	8.12%	-76.17%	-68.59%
Return on Invested Capital (ROIC)	-37.09%	-57.71%	41.62%	125.89%	-	-
Return on Capital Employed (ROCE)	13.28%	17.66%	10.99%	9.91%	-96.04%	-80.90%
Earnings Yield	5.71%	9.29%	0.50%	0.53%	-	-
Buyback Yield / Dilution	2.27%	-0.67%	-7.96%	-9.67%	-2.41%	-14.64%
Total Shareholder Return	2.27%	-0.67%	-7.96%	-9.67%	-2.41%	-14.64%

SEC Filings: 10-K · 10-Q